title: Is Myocardial Fibrosis a New Frontier for Discovery in Cardiotoxicity Related to the Administration of Anthracyclines?
authors.affiliation: From the Department of Internal Medicine, Section on Cardiovascular Medicine (G.C.M., W.G.H.), Department of Pathology, Section on Comparative Medicine (G.C.M.), and Department of Radiological Sciences (W.G.H.), Wake Forest Health Sciences, Winston-Salem, NC.
authors.forename: Giselle C
authors.initials: GC
authors.lastname: Meléndez
authors.affiliation: From the Department of Internal Medicine, Section on Cardiovascular Medicine (G.C.M., W.G.H.), Department of Pathology, Section on Comparative Medicine (G.C.M.), and Department of Radiological Sciences (W.G.H.), Wake Forest Health Sciences, Winston-Salem, NC. ghundley@wakehealth.edu.
authors.forename: W Gregory
authors.initials: WG
authors.lastname: Hundley
mesh_terms: D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D009202:Cardiomyopathies; D066126:Cardiotoxicity; D006801:Humans; D009369:Neoplasms
chemical_list: D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents
keywords: Editorials; anthracyclines; cardiotoxicity; fibrosis; heart; left ventricular dysfunction